Genomictree Inc. (228760) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.028x

Based on the latest financial reports, Genomictree Inc. (228760) has a cash flow conversion efficiency ratio of -0.028x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.21 Billion ≈ $-2.18 Million USD) by net assets (₩115.31 Billion ≈ $78.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Genomictree Inc. net asset quality index to measure how much of total assets are equity-financed.

Genomictree Inc. - Cash Flow Conversion Efficiency Trend (2020–2025)

This chart illustrates how Genomictree Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 228760 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Genomictree Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Genomictree Inc. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
HomeToGo SE F:HTG	-0.039x
Doosan Co Ltd KO:000157	0.010x
Amway (Malaysia) Holdings Bhd KLSE:6351	0.283x
Akwel SA PA:AKW	0.048x
Adgar Investments and Development Ltd TA:ADGR	0.019x
Tah Hsin Industrial Corp TW:1315	0.013x
Tian Zheng International Precision Machinery Co Ltd TWO:6654	-0.065x
CHINA KEPEI ED. DL-00001 F:9CK	N/A

Annual Cash Flow Conversion Efficiency for Genomictree Inc. (2020–2025)

The table below shows the annual cash flow conversion efficiency of Genomictree Inc. from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see 228760 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩115.31 Billion ≈ $78.14 Million	₩-10.19 Billion ≈ $-6.91 Million	-0.088x	+19.40%
2024-12-31	₩124.32 Billion ≈ $84.25 Million	₩-13.63 Billion ≈ $-9.24 Million	-0.110x	-26.02%
2023-12-31	₩125.03 Billion ≈ $84.73 Million	₩-10.88 Billion ≈ $-7.37 Million	-0.087x	-317.38%
2022-12-31	₩107.05 Billion ≈ $72.55 Million	₩4.29 Billion ≈ $2.90 Million	0.040x	+160.38%
2021-12-31	₩115.10 Billion ≈ $78.00 Million	₩-7.63 Billion ≈ $-5.17 Million	-0.066x	+38.01%
2020-12-31	₩95.26 Billion ≈ $64.55 Million	₩-10.19 Billion ≈ $-6.90 Million	-0.107x	--

About Genomictree Inc.

KQ:228760 Korea Biotechnology

Market Cap

$190.92 Million

₩281.72 Billion KRW

Market Cap Rank

#16667 Global

#598 in Korea

Share Price

₩11730.00

Change (1 day)

+3.44%

52-Week Range

₩10280.00 - ₩32000.00

All Time High

₩38550.00